Journal Article |
| Townsend EA, Platt DM, Rowlett JK, Roma PG, Freeman KB Reinforcing effectiveness of midazolam, ethanol, and sucrose: behavioral economic comparison of a mixture relative to its component solutions. Behav Pharmacol. 2017 May 19. doi: 10.1097/FBP.0000000000000308. [Epub ahead of print] | 2017 |
| Huskinson SL, Naylor JE, Townsend EA, Rowlett JK, Blough BE, Freeman KB Self-administration and behavioral economics of second-generation synthetic cathinones in male rats. Psychopharmacology (Berl). 2017, 234(4):589-598. | 2017 |
| Vallender EJ, Goswami DB, Shinday NM, Westmoreland SV, Yao WD, Rowlett JK Transcriptomic profiling of the ventral tegmental area and nucleus accumbens in rhesus macaques following long-term cocaine self-administration. Drug Alcohol Depend. 2017, 175:9-23. | 2017 |
| Huskinson SL, Freeman KB, Petry NM, Rowlett JK Choice between variable and fixed cocaine injections in male rhesus monkeys. Psychopharmacology (Berl). 2017, doi: 10.1007/s00213-017-4659-9. [Epub ahead of print] | 2017 |
| Chandler CM, Follett ME, Porter NJ, Liang KY, Vallender EJ, Miller GM, Rowlett JK, Platt DM Persistent negative effects of alcohol drinking on aspects of novelty-directed behavior in male rhesus macaques Alcohol. 2017, 63: 19-26 | 2017 |
| Fischer BD, Platt DM, Rallapalli SK, Namjoshi OA, Cook JM, Rowlett JK Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis. Drug Alcohol Depend. 2016, 158:22-9. | 2016 |
| Meng Z, Rowlett JK Self-administration of progesterone and synthetic neuroactive steroids by male rhesus monkeys. Drug Alcohol Depend. 2016, 165:265-9 | 2016 |
| Huskinson SL, Myerson J, Green L, Rowlett JK, Woolverton WL, Freeman KB Shallow discounting of delayed cocaine by male rhesus monkeys when immediate food is the choice alternative. Exp Clin Psychopharmacol. 2016, 24:456-463. | 2016 |
| Gunter BW, Jones SA, Paul IA, Platt DM, Rowlett JK Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects. Psychopharmacology (Berl). 2016, 233:3237-47. | 2016 |
| Yasuda K, Oh K, Ren B2, Tickle TL, Franzosa EA, Wachtman LM, Miller AD, Westmoreland SV, Mansfield KG, Vallender EJ, Miller GM, Rowlett JK, Gevers D, Huttenhower C, Morgan XC Biogeography of the intestinal mucosal and luminal microbiome in the rhesus macaque. Cell Host Microbe 2015, 17: 385-91. | 2015 |
| Gunter BW, Platt DM, Rowlett JK Differential interactions engendered by benzodiazepine and neuroactive steroid combinations on schedule-controlled responding in rats. Pharmacol Biochem Behav 2015, 137: 53-9. | 2015 |
| Clayton T, Poe MM, Rallapalli S, Biawat P, Savić MM, Rowlett JK, Gallos G, Emala CW, Kaczorowski CC, Stafford DC, Arnold LA, Cook JM A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model. Int J Med Chem. 2015, 430248. doi: 10.1155/2015/430248. (Epub). | 2015 |
| Zhang J, Saur T, Duke AN, Grant SG, Platt DM, Rowlett JK, Isacson O, Yao WD Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95. J Neurogenet 2014, 28: 98-111 | 2014 |
| Huskinson SL, Naylor JE, Rowlett JK, Freeman KB Predicting abuse potential of stimulants and other dopaminergic drugs: Overview and recommendations. Neuropharmacology, Special Issue on CNS stimulants 2014, 87: 66-80. | 2014 |
| Licata SC1, Shinday NM2, Huizenga MN3, Darnell SB3, Sangrey GR3, Rudolph U1, Rowlett JK2, Sadri-Vakili G3. Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment. PLoS One. 2013 Dec 19;8(12):e84806. doi: 10.1371/journal.pone.0084806. eCollection 2013. | 2013 |
| Lynch LJ1, Sullivan KA, Vallender EJ, Rowlett JK, Platt DM, Miller GM. Trace amine associated receptor 1 modulates behavioral effects of ethanol Subst Abuse. 2013 Jun 4;7:117-26. doi: 10.4137/SART.S12110. Print 2013. | 2013 |
| Fischer BD1, Teixeira LP, van Linn ML, Namjoshi OA, Cook JM, Rowlett JK. Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation. Psychopharmacology (Berl). 2013 May;227(2):347-54. doi: 10.1007/s00213-013-2975-2. Epub 2013 Jan 26. | 2013 |
| Shinday NM, Sawyer EK, Fischer BD, Platt DM, Licata SC, Atack JR, Dawson GR, Reynolds DS, Rowlett JK. Reinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys. Neuropsychopharmacology. 2013 May;38(6):1006-14. doi: 10.1038/npp.2012.265. Epub 2012 Dec 27 | 2013 |
| Makaron L1, Moran CA, Namjoshi O, Rallapalli S, Cook JM, Rowlett JK. Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys. Pharmacol Biochem Behav. 2013 Mar;104:62-8. doi: 10.1016/j.pbb.2012.12.018. Epub 2013 Jan 2. | 2013 |
| Rüedi-Bettschen D, Rowlett JK, Rallapalli S, Clayton T, Cook JM, Platt DM. Modulation of α5 subunit-containing GABAA receptors alters alcohol drinking by rhesus monkeys. Alcohol Clin Exp Res. 2013 Apr;37(4):624-34. doi: 10.1111/acer.12018. Epub 2012 Nov 5 | 2013 |
| Namjoshi OA1, Wang ZJ, Rallapalli SK, Johnson EM Jr, Johnson YT, Ng H, Ramerstorfer J, Varagic Z, Sieghart W, Majumder S, Roth BL, Rowlett JK, Cook JM. Search for α3β₂/₃γ2 subtype selective ligands that are stable on human liver microsomes. Bioorg Med Chem. 2013 Jan 1;21(1):93-101. doi: 10.1016/j.bmc.2012.10.057. Epub 2012 Nov 15. | 2013 |
| Platt DM, Rowlett JK Nonhuman primates in drug and alcohol addiction research. In: Abee c, Mansfield K, Morris T, Tardif S, eds. Nonhuman Primates in Biomedical Research, Volume 2, Elsevier Press 2012. | 2012 |
| Birkett MA, Shinday NM, Kessler EJ, Meyer JS, Ritchie S, Rowlett JK. Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. Pharmacol Biochem Behav. 2011 Jun;98(4):544-51. doi: 10.1016/j.pbb.2011.03.006. Epub 2011 Mar 21 | 2011 |
| Fischer BD, Rowlett JK. Anticonflict and reinforcing effects of triazolam + pregnanolone combinations in rhesus monkeys. J Pharmacol Exp Ther. 2011 Jun;337(3):805-11. doi: 10.1124/jpet.111.180422. Epub 2011 Mar 16. | 2011 |
| Fischer BD1, Atack JR, Platt DM, Reynolds DS, Dawson GR, Rowlett JK. Contribution of GABA(A) receptors containing α3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys. Psychopharmacology (Berl). 2011 May;215(2):311-9. doi: 10.1007/s00213-010-2142-y. Epub 2010 Dec 30 | 2011 |
| Rowlett JK1, Kehne JH, Sprenger KJ, Maynard GD. Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals. Psychopharmacology (Berl). 2011 Apr;214(4):855-62. doi: 10.1007/s00213-010-2093-3. Epub 2010 Nov 20 | 2011 |
| Licata SC, Rowlett JK. Self-administration of bretazenil under progressive-ratio schedules: behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines. Drug Alcohol Depend 2011; 113: 157-64 | 2011 |
| Fischer BD1, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM Jr, Cook JM, Furtmüller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK. Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure. Neuropharmacology. 2010 Dec;59(7-8):612-8. doi: 10.1016/j.neuropharm.2010.08.011. Epub 2010 Aug 18 | 2010 |
| Rüedi-Bettschen D, Rowlett JK, Spealman RD, Platt DM. Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms. Psychopharmacology (Berl). 2010 Jun;210(2):169-77. doi: 10.1007/s00213-009-1705-2. Epub 2009 Oct 27. | 2010 |
| Platt DM, Rowlett JK, Spealman RD. Asymmetric generalization and interaction profiles in rhesus monkeys discriminating intravenous cocaine or intravenous heroin from vehicle. J Pharmacol Exp Ther. 2010 Mar;332(3):985-95. doi: 10.1124/jpet.109.162941. Epub 2009 Dec 4. | 2010 |
| Licata SC, Platt DM, Rüedi-Bettschen D, Atack JR, Dawson GR, Van Linn ML, Cook JM, Rowlett JK. Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes. Neuropharmacology. 2010 Feb;58(2):357-64. doi: 10.1016/j.neuropharm.2009.10.004. Epub 2009 Oct 22. | 2010 |
| Achat-Mendes C, Valdez GR, Platt DM, Rowlett JK, Spealman RD. Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine. Psychopharmacology (Berl). 2009 Jun;204(3):489-98. doi: 10.1007/s00213-009-1480-0. Epub 2009 Feb 19. | 2009 |
| Licata SC, Platt DM, Cook JM, Van Linn ML, Rowlett JK. Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys. Psychopharmacology (Berl). 2009 Apr;203(3):539-46. doi: 10.1007/s00213-008-1401-7. Epub 2008 Nov 25. | 2009 |
| Platt DM, Rowlett JK, Spealman RD. Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine. Psychopharmacology (Berl). 2008 Oct;200(2):167-76. doi: 10.1007/s00213-008-1191-y. Epub 2008 May 29. | 2008 |
| Han D1, Holger Försterling F, Li X, Deschamps JR, Parrish D, Cao H, Rallapalli S, Clayton T, Teng Y, Majumder S, Sankar S, Roth BL, Sieghart W, Furtmuller R, Rowlett JK, Weed MR, Cook JM. A study of the structure-activity relationship of GABA(A)-benzodiazepine receptor bivalent ligands by conformational analysis with low temperature NMR and X-ray analysis. Bioorg Med Chem. 2008 Oct 1;16(19):8853-62. doi: 10.1016/j.bmc.2008.08.072. Epub 2008 Sep 2. | 2008 |
| Licata SC1, Rowlett JK. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav. 2008 Jul;90(1):74-89. doi: 10.1016/j.pbb.2008.01.001. Epub 2008 Jan 12. | 2008 |
| Rowlett JK Subtype-selective GABAA/benzodiazepine receptor ligands for the treatment of anxiety disorders. In: Blanchard RJ, Blanchard DC, Griebel G, Nutt D, editors. Handbook of anxiety and fear. New York: Academic Press; 2008. p.223-40. (Huston JP, editor. Handbook of behavioral neuroscience: vol.17.). | 2008 |
| Valdez GR, Platt DM, Rowlett JK, Rüedi-Bettschen D, Spealman RD. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. J Pharmacol Exp Ther. 2007 Nov;323(2):525-33. Epub 2007 Aug 16. | 2007 |
| Platt DM, Rowlett JK, Spealman RD Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys. J Pharmacol Exp Ther. 2007 Aug;322(2):894-902. Epub 2007 May 15 | 2007 |
| Rowlett JK, Lelas S. Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses. Exp Clin Psychopharmacol. 2007 Aug;15(4):328-37. | 2007 |
| Rowlett JK1, Platt DM, Yao WD, Spealman RD. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J Pharmacol Exp Ther. 2007 Jun;321(3):1135-43. Epub 2007 Mar 9. | 2007 |
| Rowlett JK, Duke AN, Platt DM Abuse and dependence liability of GABAA receptor modulators: Antecedents and pharmacology. IN; Enna SJ, Mohler H, editors. The GABA receptors. Totowa: Humana Press: 2007.p.143-68 | 2007 |
| Duke AN, Platt DM, Cook JM, Huang S, Yin W, Mattingly BA, Rowlett JK. Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes. Psychopharmacology (Berl). 2006 Aug;187(3):321-30. Epub 2006 Jun 17. | 2006 |
| Rowlett JK1, Lelas S, Tornatzky W, Licata SC. Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors. Psychopharmacology (Berl). 2006 Jan;184(2):201-11. Epub 2005 Dec 24 | 2006 |
| Tiefenbacher S1, Fahey MA, Rowlett JK, Meyer JS, Pouliot AL, Jones BM, Novak MA. The efficacy of diazepam treatment for the management of acute wounding episodes in captive rhesus macaques. Comp Med. 2005 Aug;55(4):387-92 | 2005 |
| Licata SC1, Platt DM, Cook JM, Sarma PV, Griebel G, Rowlett JK Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. J Pharmacol Exp Ther. 2005 Jun;313(3):1118-25. Epub 2005 Feb 1. | 2005 |
| Platt DM1, Duggan A, Spealman RD, Cook JM, Li X, Yin W, Rowlett JK. Contribution of alpha 1GABAA and alpha 5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys. J Pharmacol Exp Ther. 2005 May;313(2):658-67. Epub 2005 Jan 13. | 2005 |
| Lee B1, Platt DM, Rowlett JK, Adewale AS, Spealman RD Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J Pharmacol Exp Ther. 2005 Mar;312(3):1232-40. Epub 2004 Nov 18 | 2005 |
| Rowlett JK1, Rodefer JS, Spealman RD. Self-Administration of cocaine-opioid combinations by rhesus monkeys: evaluation of the role of mu receptor efficacy using labor supply analysis J Pharmacol Exp Ther. 2005 Mar;312(3):1289-97. Epub 2004 Nov 18. | 2005 |
| Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):915-20. Epub 2005 Jan 11. | 2005 |
| Rowlett JK1, Cook JM, Duke AN, Platt DM. Selective antagonism of GABAA receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs. CNS Spectr. 2005 Jan;10(1):40-8. | 2005 |
| Rowlett JK Getting back to basics: Commentary on McSweeney, Murphy, and Kowal “Regulation of drug taking by sensitization and habituation”. Exp Clin Psychopharmacol 2005; 13: 187-9. | 2005 |
| Rowlett JK1, Platt DM, Spealman RD. Cocaine-like discriminative stimulus effects of heroin: modulation by selective monoamine transport inhibitors. J Pharmacol Exp Ther. 2004 Jul;310(1):342-8. Epub 2004 Feb 25 | 2004 |
| de Almeida RM, Rowlett JK, Cook JM, Yin W, Miczek KA. GABAA/alpha1 receptor agonists and antagonists: effects on species-typical and heightened aggressive behavior after alcohol self-administration in mice. Psychopharmacology (Berl). 2004 Mar;172(3):255-63. Epub 2003 Nov 25. | 2004 |
| Platt DM1, Rowlett JK, Izenwasser S, Spealman RD. Opioid partial agonist effects of 3-O-methylnaltrexone in rhesus monkeys. J Pharmacol Exp Ther. 2004 Mar;308(3):1030-9. Epub 2003 Nov 21. | 2004 |
| Spealman RD, Lee B, Tiefenbacher S, Platt DM, Rowlett JK, Khroyan TV Triggers of relapse: nonhuman primate models of reinstated drug seeking. In: Bevins R, Bardo MT, editors. Motivational factors in the etiology of drug abuse. Lincoln (NE): University of Nebraska Press; 2004; p. 57-84. (Nebraska symposium on motivation; vol. 50.). | 2004 |
| Khroyan TV, Platt DM, Rowlett JK, Spealman RD. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates. Psychopharmacology (Berl). 2003 Jul;168(1-2):124-31. Epub 2003 Feb 27. | 2003 |
| Platt DM, Rodefer JS, Rowlett JK, Spealman RD. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys. Psychopharmacology (Berl). 2003 Mar;166(3):298-305. Epub 2003 Feb 13. | 2003 |
| Rowlett JK, Spealman RD, Lelas S, Cook JM, Yin W. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors. Psychopharmacology (Berl). 2003 Jan;165(3):209-15. Epub 2002 Nov 6. | 2003 |
| Platt DM, Rowlett JK, Spealman RD, Cook J, Ma C Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys. Psychopharmacology (Berl). 2002 Nov;164(2):151-9. Epub 2002 Sep 4 | 2002 |
| Rowlett JK, Rodefer JS, Spealman RD. Self-administration of cocaine, alfentanil, and nalbuphine under progressive-ratio schedules: consumer demand and labor supply analyses of relative reinforcing effectiveness. Exp Clin Psychopharmacol. 2002 Nov;10(4):367-75. | 2002 |
| Platt DM1, Rowlett JK, Spealman RD. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology (Berl). 2002 Oct;163(3-4):265-82. Epub 2002 Jul 17. | 2002 |
| Lelas S1, Rowlett JK, Spealman RD, Cook JM, Ma C, Li X, Yin W. Role of GABAA/benzodiazepine receptors containing alpha 1 and alpha 5 subunits in the discriminative stimulus effects of triazolam in squirrel monkeys. Psychopharmacology (Berl). 2002 May;161(2):180-8. Epub 2002 Mar 13. | 2002 |
| Park WK, Bari AA, Jey AR, Anderson SM, Spealman RD, Rowlett JK, Pierce RC. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci. 2002 Apr 1;22(7):2916-25. | 2002 |
| Lelas S, Rowlett JK, Spealman RD. Isobolographic analysis of chlordiazepoxide and triazolam combinations in squirrel monkeys discriminating triazolam. Psychopharmacology (Berl). 2001 Nov;158(2):181-9. | 2001 |
| Platt DM, Rowlett JK, Spealman RD. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms. J Pharmacol Exp Ther. 2001 Nov;299(2):760-7. | 2001 |
| Platt DM, Rowlett JK, Spealman RD. Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys. Psychopharmacology (Berl). 2001 Sep;157(2):208-16. | 2001 |
| Rowlett JK, Spealman RD, Platt DM. Similar enhancement of the discriminative stimulus effects of cocaine and GBR 12909 by heroin in squirrel monkeys. Psychopharmacology (Berl). 2001 Sep;157(3):313-9. | 2001 |
| Rowlett JK, Tornatzky W, Cook JM, Ma C, Miczek KA. Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt). J Pharmacol Exp Ther. 2001 Apr;297(1):247-53. | 2001 |
| Lelas S, Rowlett JK, Spealman RD. Triazolam discrimination in squirrel monkeys distinguishes high-efficacy agonists from other benzodiazepines and non-benzodiazepine drugs. Psychopharmacology (Berl). 2001 Feb;154(1):96-104 | 2001 |
| Rowlett JK1, Woolverton WL. Discriminative stimulus effects of panadiplon (U-78875), a partial agonist at the benzodiazepine site, in pentobarbital-trained rhesus monkeys. Drug Alcohol Depend. 2001 Feb 1;61(3):229-36 | 2001 |
| Wilcox KM, Rowlett JK, Paul IA, Ordway GA, Woolverton WL. On the relationship between the dopamine transporter and the reinforcing effects of local anesthetics in rhesus monkeys: practical and theoretical concerns. Psychopharmacology (Berl). 2000 Dec;153(1):139-47. | 2000 |
| Rowlett JK. A labor-supply analysis of cocaine self-administration under progressive-ratio schedules: antecedents, methodologies, and perspectives. Psychopharmacology (Berl). 2000 Dec;153(1):1-16. | 2000 |
| Rowlett JK, Lelas S, Spealman RD. Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors. Eur J Pharmacol. 2000 Oct 6;406(1):R9-R10. | 2000 |
| Lelas S1, Spealman RD, Rowlett JK. Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines. Exp Clin Psychopharmacol. 2000 Aug;8(3):294-311. | 2000 |
| Rowlett JK. Regulation of drug-maintained behavior: comment on Meisch (2000)relative persistence of behavior. Exp Clin Psychopharmacol. 2000 Aug;8(3):355-6; discussion 362-5. | 2000 |
| Rowlett JK, Spealman RD, Platt DM. Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms. Psychopharmacology (Berl). 2000 Jun;150(2):191-9 | 2000 |
| Rush CR1, Baker RW, Rowlett JK. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans. Exp Clin Psychopharmacol. 2000 Feb;8(1):22-36. | 2000 |
| Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, Katz JL. 3'- and 4'-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psychopharmacology (Berl). 2000 Jan;147(4):426-35 | 2000 |
| Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 2000; 294: 680-7. | 2000 |
| Platt DM, Rowlett JK, Spealman RD Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. J Pharmacol Exp Ther 2000; 293: 1017-26. | 2000 |
| Rowlett JK, Spealman RD, Lelas S. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics. J Pharmacol Exp Ther. 1999 Dec;291(3):1233-41. | 1999 |
| Spealman RD1, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV. Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav. 1999 Oct;64(2):327-36. | 1999 |
| Platt DM, Grech DM, Rowlett JK, Spealman RD Discriminative stimulus effects of morphine in squirrel monkeys: stimulants, opioids, and stimulant-opioid combinations. J Pharmacol Exp Ther. 1999 Sep;290(3):1092-100 | 1999 |
| Rowlett JK1, Wilcox KM, Woolverton WL. Discriminative stimulus effects of ethyl-beta-carboline-3-carboxylate at two training doses in rats. Psychopharmacology (Berl). 1999 Aug;145(3):324-32 | 1999 |
| Rowlett JK1, Winger G, Carter RB, Wood PL, Woods JH, Woolverton WL Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys. Psychopharmacology (Berl). 1999 Jul;145(2):205-12. | 1999 |
| Woolverton WL, Rowlett JK, Winger G, Woods JH, Gerak LR, France CP. Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys. Drug Alcohol Depend. 1999 Apr 1;54(2):137-43. | 1999 |
| Rowlett JK1, Spealman RD. Opioid enhancement of the discriminative stimulus effects of cocaine: evidence for involvement of mu and delta opioid receptors. Psychopharmacology (Berl). 1998 Nov;140(2):217-24 | 1998 |
| Rowlett JK, Wilcox KM, Woolverton WL. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone. J Pharmacol Exp Ther. 1998 Jul;286(1):61-9. | 1998 |
| Woolverton WL, Rowlett JK. Choice maintained by cocaine or food in monkeys: effects of varying probability of reinforcement. Psychopharmacology (Berl). 1998 Jul;138(1):102-6. | 1998 |
| Rowlett JK1, Woolverton WL Discriminative stimulus effects of benzodiazepine agonists and partial agonists in pentobarbital-trained rhesus monkeys. Behav Pharmacol. 1998 Mar;9(2):81-92. | 1998 |
| Robinet PM, Rowlett JK, Bardo MT Individual differences in novelty-induced activity and the rewarding effects of novelty and amphetamine in rats. Behav Pro 1998; 44: 1-9. | 1998 |
| Rowlett JK1, Woolverton WL Self-administration of cocaine and heroin combinations by rhesus monkeys responding under a progressive-ratio schedule. Psychopharmacology (Berl). 1997 Oct;133(4):363-71 | 1997 |
| Rowlett JK1, Mattingly BA, Bardo MT. Locomotor activity and dopamine synthesis following 1 and 15 days of withdrawal from repeated apomorphine treatments. Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):13-8. | 1997 |
| Rowlett JK, Woolverton WL. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats. J Pharmacol Exp Ther. 1997 Jan;280(1):162-73. | 1997 |
| Rush CR1, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. J Pharmacol Exp Ther. 1997 Jan;280(1):174-88 | 1997 |
| Rowlett JK1, Woolverton WL Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Psychopharmacology (Berl). 1996 Nov;128(1):1-16. | 1996 |
| Acteo MD1, Bowman E, Butelman E, Englis JA, Harrish L, Jacobson AE, Mattson MV, Medzihradsky F, Patrick G, Rowlett JK, Smith CB, Winger G, Woods JH, Woolverton WL. Zipeprol: preclinical assessment of abuse potential. Drug Alcohol Depend. 1996 Oct;42(2):93-104. | 1996 |
| Rowlett JK1, Massey BW, Kleven MS, Woolverton WL. Parametric analysis of cocaine self-administration under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology (Berl). 1996 Jun;125(4):361-70. | 1996 |
| Mattingly BA1, Fields SE, Langfels MS, Rowlett JK, Robinet PM, Bardo MT. Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine. Psychopharmacology (Berl). 1996 May;125(1):33-42. | 1996 |
| Mattingly BA1, Rowlett JK, Ellison T, Rase K Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacol Biochem Behav. 1996 Mar;53(3):481-6 | 1996 |
| Rowlett JK1, Woolverton WL. Evaluation of the effects of cocaine, heroin and naltrexone, alone and in combination, on milk drinking in rats. Behav Pharmacol. 1995 Dec;6(8):821-829 | 1995 |
| English JA1, Rowlett JK, Woolverton WL. Unit-price analysis of opioid consumption by monkeys responding under a progressive-ratio schedule of drug injection. J Exp Anal Behav. 1995 Nov;64(3):361-71. | 1995 |
| Pierce RC1, Rowlett JK, Rebec GV, Bardo MT. Ascorbate potentiates amphetamine-induced conditioned place preference and forebrain dopamine release in rats. Brain Res. 1995 Aug 7;688(1-2):21-6. | 1995 |
| Rowlett JK1, Mattingly BA, Bardo MT. Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists. Synapse. 1995 Jul;20(3):209-16. | 1995 |
| Bardo MT1, Bowling SL, Rowlett JK, Manderscheid P, Buxton ST, Dwoskin LP. Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine. Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):397-405. | 1995 |
| Bardo MT1, Rowlett JK, Harris MJ. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev. 1995 Spring;19(1):39-51 | 1995 |
| Rowlett JK1, Gibson TR, Bardo MT. Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference in rats. Pharmacol Biochem Behav. 1994 Sep;49(1):241-5. | 1994 |
| Crawford CA1, Rowlett JK, McDougall SA, Bardo MT. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ. Eur J Pharmacol. 1994 Feb 3;252(2):225-31. | 1994 |
| Neisewander JL1, Nonneman AJ, Rowlett JK, Bardo MT. Impaired supersensitivity to morphine following chronic naltrexone treatment in senescent rats. Neurobiol Aging. 1994 Jan-Feb;15(1):91-7. | 1994 |
| Rowlett JK1, Mattingly BA, Bardo MT. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation. Synapse. 1993 Jun;14(2):160-8 | 1993 |
| Bardo MT, Bowling SL, Robinet PM, Rowlett JK, Lacy M, Mattingly BA Role of D1 and D2 receptors in novelty-maintained place preference. Exp Clin Psychopharmacol 1993;1: 101-9. | 1993 |
| Mattingly BA1, Rowlett JK, Lovell G. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine. Psychopharmacology (Berl). 1993;110(3):320-6 | 1993 |
| Bowling SL, Rowlett JK, Bardo MT The effects of environmental enrichment on amphetamine-stimulated locomotor activity, dopamine synthesis and dopamine release. Neuropharmacology 1993; 32: 885-93. | 1993 |
| Crawford CA1, McDougall SA, Rowlett JK, Bardo MT. Depletion of dopamine binding sites and changes in dopamine and dihydroxyphenylacetic acid levels in 17- and 90-day-old rat striatum after irreversible receptor antagonism. Neurosci Lett. 1992 Mar 30;137(2):265-9. | 1992 |
| Blanchard DC1, Cholvanich P, Blanchard RJ, Clow DW, Hammer RP Jr, Rowlett JK, Bardo MT. Serotonin, but not dopamine, metabolites are increased in selected brain regions of subordinate male rats in a colony environment. Brain Res. 1991 Dec 24;568(1-2):61-6. | 1991 |
| Rowlett JK1, Pedigo NW Jr, Bardo MT. Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats. Pharmacol Biochem Behav. 1991 Dec;40(4):829-34. | 1991 |
| Rowlett JK1, Mattingly BA, Bardo MT. Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats. Neuropharmacology. 1991 Feb;30(2):191-7. | 1991 |
| Mattingly BA1, Rowlett JK, Graff JT, Hatton BJ. Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine. Psychopharmacology (Berl). 1991;105(4):501-7. | 1991 |
| Pierce RC1, Rowlett JK, Bardo MT, Rebec GV. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding. Neuroscience. 1991;45(2):373-8. | 1991 |
| Mattingly BA, Rowlett JK. Effects of repeated apomorphine and haloperidol treatments on subsequent behavioral sensitivity to apomorphine. | 1989 |
| Neisewander JL1, Rowlett JK, Nonneman AJ, Bardo MT. Up-regulation of opiate receptors following chronic naltrexone treatment in mature and aged male and female rats. Prog Clin Biol Res. 1989;292:471-6. | 1989 |
| France CP, Gerak LR, Rowlett JK, Woolverton WL, Winger G, Briscoe RJ Progress report from the testing program for stimulant and depressant drugs (1999). In: Harris LS, editor. Problems of drug dependence 1999: 67th annual scientific meeting, The College on Problems od Drug dependence, Inc., NIDA Research Monograph 180, 2000. p. 423-33. | 1999 |
| Winger G, Rowlett JK, Woolverton WL, France CP, Gerak LR Progress report from the testing program for stimulant and depresant drugs (1998). In: Harris LS, editor. Problems of drug dependence 1998: 60th annual scientfic meeting, The College on Problems of Drug Dependence, Inc., NIDA Research Monograph 179, 1998. p. 381-92. | 1998 |
| France CP, Gerak LR, Rowlett JK, Woolverton W, Winger G, Woods JH Progess report from the testing program for stimulant and depressant drugs (1997). In: Harris LS, editor. Problems of drug dependence 1997:59th annual scintific meeting, The College on Problems of Drug Dependence, Inc., NIDA Research Monograph 178, 1997.p.429-39. | 1997 |
| Rowlett JK, Negus SS, Shippenbet TS, Mello NK, Walsh SL, Spealman RD Combined cocaine and opioid abuse: from neurobiology to the clinic. In: Harris LS, editor. Problems of drug depencence 1997:59th annual scientific meeting, The College on Problems of Drug Dependence, Inc., NIDA Research Monograph 178, 1998. p. 55-7. | 1997 |
| English JA, Rowlett JK, Woolverton WL, Patrick GA, Harris LS, Winger G, Woods JH Progress report from the testing program for stimulant and depressant drugs (1995). In: Harris LS, editor. Problems of drug dependence 1995: 57th annual scientific meeting, The College on Problems of Drug Dependence, Inc., NIDA Research Monograph 162, 1996. p. 452-68. | 1995 |
| Winger g, Woolverton WL, Rowlett JK, English JA, Patrick GA, Nader MA, McDaniel RE, Hawkins WT, Massey BW, Harris LS, Woods JH Progress report from the testing program for stimulant and depressant drugs (1994). In: Harris LS, editor. Problems of drug dependence 1994: 56th annual scientific meeting, The College on Problems of Drug Dependence, Inc., NIDA Research Monograph 152, 1995.p. 105-16. | 1994 |
